radical excision

根治性切除术
  • 文章类型: Journal Article
    肌萎缩症是许多类型癌症预后不良的公认预测指标,肌酐/胱抑素C比值(CCR)降低是代谢紊乱和癌症患者不良结局的已知指标.尽管有这些知识,CCR和肌萎缩在预测接受根治性手术的胆管癌(CCA)患者预后中的意义仍不确定.
    收集2017年1月至2022年3月在青岛大学附属医院接受首次根治性切除术的757例胆管癌患者的数据。根据纳入和排除标准,149例患者最终纳入回顾性研究队列。各种临床病理,血清学,入院时收集放射学数据。使用sliceOmatic软件在计算机断层扫描(CT)图像上评估了肌肉骨化。该研究使用受试者工作特性(ROC)曲线分析来确定CCR的临界值,基于Kaplan-Meier方法预测总生存期(OS)。采用单变量和多变量Cox回归分析来确定与OS和RFS相关的危险因素。
    确定为肌骨形成队列的组由79名患者组成,平均年龄为64.3±7.8岁。ROC曲线分析显示最佳临界CCR值为10.834。发现低CCR≤10.834和肌骨形成与不良OS和RFS结局相关(分别为P=0.022;P=0.017;P=0.038;P=0.030)。此外,骨化病且CCR≤10.834的患者的OS和RFS结局最差(P=0.035;P=0.027).
    CCA患者根治性切除术后,肌萎缩和CCR的存在与预后呈负相关.通过结合CCR和肌肉骨化可以更准确地预测OS和RFS,与单独的CCR相比。
    UNASSIGNED: Myosteatosis is a well-established predictor of poor prognosis in many types of cancer, and a decreased Creatinine/Cystatin C ratio (CCR) is a known indicator of unfavorable outcomes in patients with metabolic disorders and cancer. Despite this knowledge, the significance of concurrent CCR and myosteatosis in predicting the prognosis of patients with cholangiocarcinoma (CCA) who undergo radical surgery remains uncertain.
    UNASSIGNED: Data from 757 patients with cholangiocarcinoma who underwent the first radical resection in the Affiliated Hospital of Qingdao University from January 2017 to March 2022 were collected. According to the inclusion and exclusion criteria, 149 patients were finally included in the retrospective study cohort. Various clinicopathological, serological, and radiological data were collected at admission. Myosteatosis was evaluated using sliceOmatic software on computed tomography (CT) images. The study used receiver operating characteristic (ROC) curve analysis to determine the critical value of CCR, which predicts overall survival (OS) based on the Kaplan-Meier method. Univariate and multivariate Cox regression analyses were employed to identify the risk factors associated with OS and RFS confidently.
    UNASSIGNED: The group identified as the myosteatosis cohort consisted of 79 patients with an average age of 64.3 ± 7.8 years. The ROC curve analysis revealed an optimal critical CCR value of 10.834. A low CCR ≤ 10.834 and myosteatosis were found to be associated with poor OS and RFS outcomes (P = 0.022; P = 0.017; P = 0.038; P = 0.030 respectively). Moreover, patients with myosteatosis and a CCR ≤ 10.834 had the worst OS and RFS outcomes (P = 0.035; P = 0.027).
    UNASSIGNED: After radical excision in CCA patients, the presence of myosteatosis and CCR had a negative correlation with prognosis. A more accurate prediction of OS and RFS was possible by combining CCR and myosteatosis, compared to CCR alone.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    年龄显著影响直肠癌根治术(RE)后患者的预后,局部切除术(LE)是RE的替代外科手术。比较不同年龄段LE和RE对直肠癌患者生存预后的影响。从SEER数据库获得2010年至2017年诊断为LE或RE治疗的直肠腺癌的患者。主要结果是5年OS和CSS。最终共纳入11,170名患者,LE和RE组有490例患者,分别,1:1倾向评分匹配后。<50岁和50-66岁组的LE后5年OS和CSS明显优于>66岁组(5年OS:95.70%vs88.40%vs67.00%,P<0.001;5年CSS:95.70%vs96.30%vs82.60%,P<0.001)。在<50、50~66和>66岁组,LE和RE的5年OS和CSS差异无统计学意义(P>0.05)。多因素分析显示年龄>66岁,分化差或未分化(III/IV级),肿瘤大小3~5cm是LE后5年OS的独立危险因素;年龄>66岁,神经周浸润,肿瘤大小3~5cm是LE后5年CSS的独立危险因素。我们发现,接受LE治疗的年轻直肠癌患者的生存预后明显优于老年(>66岁)患者,三个年龄组的直肠癌患者的生存预后在LE和RE之间相似。
    Age significantly affects the prognosis of patients with rectal cancer after radical excision (RE), and local excision (LE) is an alternative surgical procedure to RE. To compare the survival prognosis in different age groups of LE versus RE for rectal cancer. Patients diagnosed with rectal adenocarcinoma treated by LE or RE from 2010 to 2017 were obtained from the SEER database. The primary outcomes are 5-year OS and CSS. A total of 11,170 patients were eventually included, and there were 490 patients in LE and RE groups, respectively, after 1:1 propensity score matching. The 5-year OS and CSS after LE were significantly better in < 50 years and 50-66 years groups than in > 66 years group (5-year OS: 95.70% vs 88.40% vs 67.00%, P < 0.001; 5-year CSS: 95.70% vs 96.30% vs 82.60%, P < 0.001). No statistical significance was found for the differences in 5-year OS and CSS between LE and RE in < 50, 50-66, and > 66 years group (P > 0.05). Multivariate analysis showed age > 66 years, poorly differentiated or undifferentiated (Grade III/IV), and tumor size 3 to 5 cm was independent risk factors for 5-year OS after LE; age > 66 years, perineural invasion, and tumor size 3 to 5 cm were the 5-year CSS independent risk factors for after LE. We found that the survival prognosis of younger rectal cancer patients treated with LE was significantly better than older (> 66 years) patients, and the survival prognosis of rectal cancer patients in the three age groups was similar between LE and RE.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    直肠癌根治术(RE)具有较高的死亡率和发病率风险,而局部切除术(LE)可以降低这些术后风险。然而,LE的长期利益仍有争议。
    研究LE与RE在T1和T2直肠癌中的有效性。
    使用PubMed和ClinicalTrials.gov等关键数据库进行了系统评价和荟萃分析。仅纳入队列研究和随机对照试验。使用RevMan5.4工具进行数据分析。评估了研究的临床和统计异质性,I2>75%被认为是高度异质的。测量的主要结果是5年总生存期(OS)和5年无病生存期(DFS)。还对仅T1患者进行了亚组分析,没有辅助化疗/放疗。
    共有18项研究纳入最终荟萃分析。四个是RCT,其他15项为回顾性队列研究.一项纳入研究的数据来自RCT和非RCT研究组。9项研究是多中心或国家研究,而9项是单中心研究。OS:RR0.95,95%置信区间(CI)[0.91,0.99]和DFS:RR0.93,95%CI[0.87,1.01]之间的风险比(RR)没有差异。OS:RR1.41,95%CI[1.14,1.74]和DFS:RR1.95,95%CI[1.36,2.78]的危险比较低,与LE相比。较低的复发率与RE相关。由于研究之间的临床异质性,使用随机效应模型(不同的外科手术,肿瘤分期,辅助化疗或放疗)。
    用于早期直肠癌的LE的5年OS和DFS比RE低,局部复发率较高。然而,LE与较低的术后早期死亡率相关,与RE相比,发病率和住院时间。
    UNASSIGNED: Radical excision (RE) for rectal cancer carries a higher risk of mortality and morbidity, while local excision (LE) could decrease these postoperative risks. However, the long-term benefit of LE is still debatable.
    UNASSIGNED: To study the effectiveness of LE versus RE in T1 and T2 rectal cancer.
    UNASSIGNED: A systematic review and meta-analysis was conducted using key databases like PubMed and ClinicalTrials.gov. Only cohort studies and randomized controlled trials were included. RevMan 5.4 tool was used for data analysis. Both clinical and statistical heterogeneity of the studies were assessed, and I2 >75% was considered as highly heterogeneous. The primary outcomes being measured were 5-year overall survival (OS) and 5-year disease free survival (DFS). A subgroup analysis of patients with T1-only was also conducted, without adjuvant chemo/radiotherapy.
    UNASSIGNED: A total of 18 studies were included for final meta-analysis. Four were RCTs, while the other 15 were retrospective cohort studies. One included study had data from both RCT and non-RCT study groups. Nine studies were multicentered or national studies while nine were unicentral.There was no difference in risk ratio (RR) between OS: RR 0.95, 95% Confidence Interval (CI) [0.91, 0.99] and DFS: RR 0.93, 95% CI [0.87, 1.01]. There were lower hazards ratios in OS: RR 1.41, 95% CI [1.14, 1.74] and DFS: RR 1.95, 95% CI [1.36, 2.78] with radical, as compared to LE. Lower recurrence rate was associated with RE. Random effect model was used due to clinical heterogeneity between studies (different surgical procedures, tumor staging, adjuvant chemo or radiotherapy).
    UNASSIGNED: LE for early-stage rectal cancer has lower 5-year OS and DFS than RE, with higher local recurrence rate. However, LE is associated with lower early postoperative mortality, morbidity and length of stay as compared to RE.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Meta-Analysis
    背景:对于在新辅助化疗(nCRT)或完全新辅助治疗(TNT)后已达到临床完全缓解(cCR)的中低位直肠癌,观察等待(WW)策略或手术已在临床上广泛使用,但这两种治疗策略都存在争议.
    目的:本研究的目的是比较观察和等待策略或手术方法治疗完全缓解的直肠癌的肿瘤学结果,并报告两种治疗策略的循证临床优势。
    方法:在7个国家和国际数据库中搜索临床试验,比较观察和等待策略与手术治疗对临床完全缓解的直肠癌患者肿瘤预后的影响。
    结果:就肿瘤学结果而言,观察并等待策略与手术治疗在总生存期(OS)方面没有显着差异(HR=0.92,95%CI(0.52,1.64),P=0.777),亚组分析显示,WW与局部切除术(LE)和根治性手术(RS)之间的5年无病生存率(5年DFS)没有显着差异(HR=1.76,95%CI(0.97,3.19),P=0.279;HR=1.98,95%CI(0.95,4.13),P=0.164),远处转移率(RR=1.12,95%CI(0.73,1.72),P=0.593),死亡率(RR=1.62,95%CI(0.93,2.84),P=0.09),和器官保存率(RR=1.05,95%CI(0.94,1.17),P=0.394),对局部复发率的结果指标(RR=2.09,95%CI(1.44,3.03),P<0.001)和造口率(RR=0.35,95%CI(0.20,0.61),P<0.001)。WW组与手术医治组之间有明显性差别。
    结论:操作系统没有差异,5年DFS,远处转移,WW策略组和手术治疗组之间的死亡率。与局部切除术相比,WW策略没有增加局部复发的风险,但与根治性手术相比,局部复发的风险可能更高。在造口率方面,WW组明显优于手术组;与根治性切除术相比,WW策略在保持器官完整性方面明显优于手术组。因此,对于在临床上完全缓解直肠癌的情况下表现出对器官保存和吻合口形成有深刻倾向的患者,可以考虑将WW策略作为外科干预的实用替代方案。是的,然而,最重要的是要强调,这种战略的部署应在多学科团队管理的范围内和致力于直肠癌管理的专业中心内精心进行。
    BACKGROUND: A watch-and-wait (WW) strategy or surgery for low to intermediate rectal cancer that has reached clinical complete remission (cCR) after neoadjuvant chemotherapy (nCRT) or total neoadjuvant therapy (TNT) has been widely used in the clinic, but both treatment strategies are controversial.
    OBJECTIVE: The aim of this study was to compare the oncologic outcomes of a watch-and-wait strategy or a surgical approach to treat rectal cancer in complete remission and to report the evidence-based clinical advantages of the two treatment strategies.
    METHODS: Seven national and international databases were searched for clinical trials comparing the watch-and-wait strategy with surgical treatment for oncological outcomes in patients with rectal cancer in clinical complete remission.
    RESULTS: In terms of oncological outcomes, there was no significant difference between the watch-and-wait strategy and surgical treatment in terms of overall survival (OS) (HR = 0.92, 95% CI (0.52, 1.64), P = 0.777), and subgroup analysis showed no significant difference in 5-year disease-free survival (5-year DFS) between WW and both local excision (LE) and radical surgery (RS) (HR = 1.76, 95% CI (0.97, 3.19), P = 0.279; HR = 1.98, 95% CI (0.95, 4.13), P = 0.164), in distant metastasis rate (RR = 1.12, 95% CI (0.73, 1.72), P = 0.593), mortality rate (RR = 1.62, 95% CI (0.93, 2.84), P = 0.09), and organ preservation rate (RR = 1.05, 95% CI (0.94, 1.17), P = 0.394) which were not statistically significant and on the outcome indicators of local recurrence rate (RR = 2.09, 95% CI (1.44, 3.03), P < 0.001) and stoma rate (RR = 0.35, 95% CI (0.20, 0.61), P < 0.001). There were significant differences between the WW group and the surgical treatment group.
    CONCLUSIONS: There were no differences in OS, 5-year DFS, distant metastasis, and mortality between the WW strategy group and the surgical treatment group. The WW strategy did not increase the risk of local recurrence compared with local resection but may be at greater risk of local recurrence compared with radical surgery, and the WW group was significantly better than the surgical group in terms of stoma rate; the WW strategy was evidently superior in preserving organ integrity compared to radical excision. Consequently, for patients who exhibit a profound inclination towards organ preservation and the evasion of stoma formation in the scenario of clinically complete remission of rectal cancer, the WW strategy can be contemplated as a pragmatic alternative to surgical interventions. It is, however, paramount to emphasize that the deployment of such a strategy should be meticulously undertaken within the ambit of a multidisciplinary team\'s management and within specialized centers dedicated to rectal cancer management.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Systematic Review
    到目前为止,一些研究比较了局部切除(LE)和根治性切除(RE)对直肠胃肠道间质瘤(GIST)的手术和肿瘤学结果,但是有些小系列的数量有限。该协议概述了系统评价和荟萃分析的计划范围和方法,该方法将比较直肠GIST患者LE和RE的手术和肿瘤学结果。
    该协议是根据PRISMA-P指南提出的。PubMed,Embase,WebofScience,系统检索Cochrane图书馆和万方数据库。此外,将手动筛选所有纳入文章的参考列表,以添加其他符合条件的研究.我们将在这项研究中包括随机对照试验(RCTs)和非随机研究(NRS)。评估的主要结果将是R0切除率和无病生存率,而次要结果将包含总体生存率,逗留时间,肿瘤破裂率及并发症。两名评审员将独立筛选和选择研究,从纳入的研究中提取数据,并评估纳入研究的偏倚风险。本方案详述了预先计划的亚组分析和敏感性分析。证据体的强度将使用等级进行评估。
    本综述和荟萃分析将对当前有关LE和RE在直肠GIST患者中应用的证据进行全面评估。这篇综述的发现将作为未来研究的基础,并强调其对临床实践的意义。
    PROSPERO(CRD42017078338),https://www.crd.约克。AC.uk/PROSPERO/display_record。php?RecordID=387409,PROSPEROCRD42017078338。
    UNASSIGNED: To date, several studies have compared the surgical and oncological outcomes of local excision (LE) and radical excision (RE) for rectal gastrointestinal stromal tumors (GISTs), but some have limited numbers of small series. This protocol outlines the planned scope and methods for a systematic review and meta-analysis that will compare the surgical and oncological outcomes of LE and RE in patients with rectal GISTs.
    UNASSIGNED: This protocol is presented in accordance with the PRISMA-P guideline. PubMed, Embase, Web of Science, Cochrane Library and Wanfang database will be systematically searched. Furthermore, reference lists of all included articles will be screened manually to add other eligible studies. We will include randomized controlled trials (RCTs) and non-randomized studies (NRS) in this study. The primary outcomes evaluated will be R0 resection rate and disease-free survival, while the secondary outcomes will contain overall survival, length of stay, tumor rupture rate and complications. Two reviewers will independently screen and select studies, extract data from the included studies, and assess the risk of bias of the included studies. Preplanned subgroup analyses and sensitivity analyses are detailed within this protocol. The strength of the body of evidence will be assessed using GRADE.
    UNASSIGNED: This review and meta-analysis will provide a comprehensive evaluation of the current evidence concerning the application of LE and RE in patients with rectal GISTs. The findings from this review will serve as a foundation for future research and emphasize the implications for clinical practice.
    UNASSIGNED: PROSPERO (CRD42017078338), https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=387409, PROSPERO CRD42017078338.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    背景:淋巴瘤(LH)是最常见的淋巴管瘤类型,但它很少发生在前臂。它可能显示局部侵入行为,但是是良性的。
    方法:一位42岁的妇女出现在我们医院,她的右前臂有一个长条状肿块,3年前就发现了。超声检查显示右前臂皮下有一条下背声带。进一步的磁共振成像(MRI)显示LH特有的不规则带状扩张淋巴管,T1信号强度低,T2信号强度高。根治性手术切除后,用单克隆抗体D2-40标记的囊性LH内皮细胞的苏木精-伊红(H&E)和免疫组织化学(IHC)染色显示扩张的淋巴管瘤,没有恶性肿瘤的迹象。经过7个月的随访,未见肿瘤复发,疗效满意。
    先前创伤史的组合,症状和体征,影像学评估是必要的,以提供LH的线索,但最终的诊断可能是通过切除标本的病理评估。虽然有许多治疗方式,都有不同的结果。导致肿瘤残留的完全切除是LH复发的首要原因。因此,我们认为针对LH的首选方法仍然是完全手术切除。
    结论:LH是良性的,通常无症状的病变,具有轻度的生物学行为。由于偶尔会有令人困惑的演示,类似的囊性病变仍应谨慎考虑。尽管MRI为其诊断提供了优越的优势,确诊仍需进行组织学检查.根治性病灶切除术是治疗LH的一种非常安全有效的选择。
    BACKGROUND: Lymphoma hygroma (LH) that is the most common type of lymphangioma, but it rarely occurs in the forearm. It may show localized invasive behavior, but is benign.
    METHODS: A 42-year-old woman presented to our hospital with a growing strip-like mass in the right forearm that had been detected 3 years earlier. Ultrasound examination showed a subcutaneous strip of low back vocal cords on the right forearm. Further magnetic resonance imaging (MRI) showed irregular strip-like dilated lymphatic vessels characteristic of LH with low T1 signal intensity and high T2 signal intensity. After radical surgical resection, hematoxylin-eosin (H & E) and immunohistochemical (IHC) staining of cystic LH endothelial cells labeled with monoclonal antibody D2-40 showed a dilated lymphangioma with no evidence of malignancy. After 7 months of follow-up, no tumor recurrence was seen and the effect was satisfactory.
    UNASSIGNED: A combination of previous trauma history, signs and symptoms, and imaging evaluation are necessary to provide clues to LH, but the final diagnosis is likely to be made by pathologic evaluation of the resected specimen. Although there are many treatment modalities, all also have different outcomes. The absence of complete resection resulting in a tumor remnant is the foremost cause of LH recurrence, so we believe that the preferred approach against LH remains complete surgical resection.
    CONCLUSIONS: LH is benign and generally asymptomatic lesions with mild bio-behavior. As there are occasional confusing presentations, similar cystic lesions should still be considered with caution for the disease. Although MRI provides superior advantages for its diagnosis, the confirmation of diagnosis still requires histological examination. Radical lesion resection is a very safe and effective option for the treatment of LH.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    简介化脓性汗腺炎(HS)是一种慢性炎症性疾病,腋窝是最常见的受影响的部位。彻底切除受累组织是一种确定的治疗方法。描述了许多用于重建腋窝的技术。患者和方法回顾性分析2017年8月至2020年12月期间接受广泛切除和后臂皮瓣覆盖的腋窝HS患者。结果8例患者在研究期间共做了15个皮瓣。在两组方法的帮助下,对所有八名患者同时进行了双侧根治性切除。腋窝的重建是通过双侧后臂皮瓣完成的,除了一个病人的一侧,其中进行了分层厚度的皮肤移植。所有皮瓣沉降良好,无明显并发症。在12至42个月的随访中,一名患者抱怨一侧疾病复发。所有患者的皮瓣和供体部位都很好地固定下来,没有引起明显的发病率。结论腋窝汗腺炎的根治性切除术必须在早期考虑。广泛切除后,同时使用后臂皮瓣进行双侧重建是一种简单可靠的技术,患者报告的预后良好。
    Introduction  Hidradenitis suppurativa (HS) is a chronic inflammatory disease, with the axilla being the most commonly affected site. Radical excision of the involved tissue is a definitive treatment. There are numerous techniques described for the reconstruction of the axilla. Patients and methods  Patients with axillary HS who underwent wide excision and posterior arm flap cover between August 2017 and December 2020 were reviewed. Results  A total of 15 flaps were done in eight patients in the study period. Bilateral radical excision of the disease was done simultaneously in all eight patients with the help of a two-team approach. Reconstruction of the axilla was done with a posterior arm flap bilaterally, except one side in a single patient, wherein the split-thickness skin graft was performed. All flaps settled well without significant complications. On follow-up ranging from 12 to 42 months, one patient complained of disease recurrence on one side. The flap and the donor site had settled well in all patients, causing no significant morbidity. Conclusion  Radical excision of axillary hidradenitis must be considered early on presentation. After wide excision, simultaneous bilateral reconstruction with posterior arm flap is a simple and reliable technique with an excellent patient-reported outcome.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:直肠胃肠道间质瘤(GIST)患者的手术策略选择仍存在争议。本研究旨在探讨外科手术[局部切除术(LE)与根治性切除术(RE)]影响生存结果。
    方法:本研究招募的患者的信息来自监测,流行病学,和结束结果(SEER)数据库。使用存活曲线来评估癌症特异性存活期(CSS)的差异。
    结果:LE组和RE组的CSS没有检测到显著差异。此外,在不同的T分类方面,两组之间的CSS没有观察到显著差异,N分类,肿瘤分化,肿瘤大小,区域LN手术,年龄,性别,种族,化疗,和放射治疗。T分型和年龄是影响直肠GIST患者预后的独立因素。
    结论:LE和RE术后生存时间相似,LE可以被认为是治疗直肠GIST的有效手术方法。
    BACKGROUND: The choice of surgical strategy for patients with rectal gastrointestinal stromal tumor (GIST) remains controversial. This study aims to address whether the surgical procedure [local excision (LE) vs. radical excision (RE)] influences the survival outcomes.
    METHODS: The information of the patients recruited in this study was obtained from the Surveillance, Epidemiology, and End Results (SEER) database. A survival curve was used to evaluate the differences in cancer-specific survival (CSS).
    RESULTS: No significant difference was detected in the CSS between the LE and RE groups. Also, no significant differences were observed in the CSS between the two groups with respect to different T classification, N classification, tumor differentiation, tumor size, regional LN surgery, age, gender, race, chemotherapy, and radiotherapy. The T classification and age were independent prognostic factors in rectal GIST patients.
    CONCLUSIONS: LE and RE have similar survival time after surgery, and LE could be considered as an effective surgical approach for rectal GIST.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:坐骨直肠窝是具有边界和内部结构的关键解剖位置,对功能和生活质量有不同的贡献。方法:我们强调了在这个深层解剖复杂位置进行病理处理的重要性。结果:我们提出了十步多学科手术方法;实现一期封闭和令人放心的结果的整体根治性切除术。神经鞘瘤是良性缓慢生长的神经鞘瘤。结论:盆腔神经鞘瘤很少见,仅报告了3例阴部神经。我们还提供了这种罕见病理的概述,同时承认有关坐骨直肠窝疾病管理的建议很少。
    Objective: The ischiorectal fossa is a key anatomical location with boundaries and internal structures owing distinct contributions to function and quality of life. Methods: We highlight the importance of management of pathology in this deep anatomically complex location. Results: We present a ten-step multidisciplinary surgical approach; achieving en bloc radical excision with primary closure and reassuring outcomes. Schwannomas are benign slow-growing nerve sheath tumors. Conclusions: Pelvic schwannomas are rare with only 3 reported cases of the pudendal nerve. We also offer an overview of this rare pathology whilst acknowledging a paucity of recommendations regarding management of disease of the ischiorectal fossa.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    Background  Ameloblastoma is a benign yet locally aggressive odontogenic tumor of the jaw with high recurrence rates. Despite many studies, the search is still on for the treatment approach which can render the acceptable recurrence rates with good functional and esthetic results. Methods  In this prospective study, we operated on 37 patients of mandibular ameloblastoma between 2009 and 2018. Two patients were treated with curettage and chemical sterilization of the cavity. Resection of a tumor with a 2-cm margin was performed in the rest of 35 patients. The mandibular defect was primarily reconstructed with the microvascular free fibular flap in 29 patients. Results  The follow-up ranged from 6 months to 7.7 years with a mean of 5.1 years. A tumor recurred within a year in all two patients (100%) treated with curettage. Out of 35 radical excisions, only one patient (2.85%) developed recurrence 3 years after the disease-free interval. Good mouth opening, intelligible speech, satisfactory lower jaw shape, and facial profiles were achieved in all 29 patients who were treated with primary free fibular flap. Conclusion  We prefer wide excision with 2-cm margins on each side of a tumor with the primary reconstruction of the mandible in all cases of mandibular ameloblastoma. The free fibular microvascular flap is our treatment of choice as all defects of the mandible can be reconstructed with the free fibular flap. Wide excision is the key to prevent a recurrence.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

公众号